| Current Price | $15.13 | Mkt Cap | $731.8M |
|---|---|---|---|
| Open | $14.95 | P/E Ratio | 0.00 |
| Prev. Close | $14.97 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $14.83 - $15.23 | Volume | 747,857 |
| 52-Wk Range | $10.26 - $19.00 | Avg. Daily Vol. | 595,139 |
| Current Price | $15.13 | Mkt Cap | $731.8M |
|---|---|---|---|
| Open | $14.95 | P/E Ratio | 0.00 |
| Prev. Close | $14.97 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $14.83 - $15.23 | Volume | 747,857 |
| 52-Wk Range | $10.26 - $19.00 | Avg. Daily Vol. | 595,139 |
The best Bull and Bear pitches based on recency and number of recommendations.
While the CRISPR patent dispute is happening, the hype will drive this one higher within the next couple months.
There are no pitches that meet the Top Bear criteria. Explain
If this upsets you, start recommending pitches below!
Read the most recent pitches from players about NTLA.
Recs
meridius91
(81.66)
Submitted: 6/6/2019 3:05:59 PM :
Start Price:
$14.40
NASDAQ:NTLA Score:
-4.06
CRISPR basket, along with EDIT and CRSP. Good partnerships and exicting technological pipeline.
Recs
JohnCLeven
(23.07)
Submitted: 8/24/2018 3:57:41 PM :
Start Price:
$28.73
NASDAQ:NTLA Score:
-55.26
Taking a flier on the 3 public CRISPR related stocks. All three combined at valued <$5B which seems low considering the future of gene editing in healthcare. All 3 could be worthless, but I wouldn't be shocked if one of these ends up a 100X bagger someday.
Recs
InvestRight
(81.55)
Submitted: 6/13/2018 10:00:03 AM :
Start Price:
$24.94
NASDAQ:NTLA Score:
-50.49
Recent 11% drop is unwarranted and now is the time to buy into CRISPR stocks. Outperform.
Find the members with the highest scoring picks in NTLA.
cruisin25 (< 20) Score: +65.29
The Score Leader is the player with the highest score across all their picks in NTLA.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| Playa14 | < 20 | 10/17/2019 |
|
5Y | $11.40 | +32.76% | +3.86% | +28.90 | 0 Comment | |
| TraderEnvy | < 20 | 10/4/2019 |
|
5Y | $11.94 | +26.76% | +6.54% | +20.22 | 0 Comment | |
| capstrarian | 91.72 | 1/15/2019 |
|
5Y | $14.20 | +6.58% | +19.27% | +12.69 | 0 Comment | |
| stereotyp72 | < 20 | 11/5/2019 |
|
5Y | $13.78 | +9.83% | +0.90% | +8.93 | 0 Comment | |
| demetri | 31.14 | 2/25/2019 |
|
1Y | $14.02 | +7.95% | +10.55% | +2.59 | 0 Comment | |
| clangmead | 30.09 | 12/28/2018 |
|
5Y | $12.51 | +20.98% | +24.83% | -3.84 | 0 Comment | |
| meridius91 | 81.66 | 6/6/2019 |
|
5Y | $14.40 | +5.10% | +9.17% | -4.06 | 1 Comment | |
| boomfool | < 20 | 6/3/2019 |
|
5Y | $14.11 | +7.26% | +13.52% | -6.25 | 0 Comment | |
| CMFMLove | 35.49 | 6/13/2017 |
|
5Y | $12.67 | +19.46% | +27.20% | -7.74 | 1 Comment | |
| NextGenStock | < 20 | 1/14/2019 |
|
5Y | $13.94 | +8.57% | +20.82% | -12.25 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
